Curing Death
  Recent News |  Archives |  Tags |  About |  Newsletter |  Submit News |  Advertise With Us |  Subscribe to CuringDeath.com RSS Fee Subscribe
New Articles
Researchers find clue to stopping breast-cancer metastasis 11/20/2008

Breaking BubR1 mimics genetic shuffle seen in cancer cells 11/20/2008

'Let the sunshine in' to protect your heart this winter 11/20/2008

The relative risk of brain cancer 11/18/2008

Breakthrough in cell-type analysis offers new ways to study development and disease 11/18/2008

Researchers identify toehold for HIV's assault on brain 11/18/2008

No protective effect on cancer from long-term vitamin E or vitamin C supplementation 11/18/2008

Novel 4-drug combination proves safe for lung cancer treatment 11/18/2008

Protein compels ovarian cancer cells to cannibalize themselves 11/17/2008

Scientists find cell pathway driving a deadly sub-type of breast cancer 11/17/2008

Tiny sacs released by brain tumor cells carry information that may guide treatment 11/17/2008

Proton therapy and concurrent chemotherapy may reduce bone marrow toxicity in advanced lung cancer 11/17/2008

Researchers develop a new way to study how breast cancer spreads 11/17/2008

Researchers ID molecule linked to aggressive cancer growth, spread 11/16/2008

How eating red meat can spur cancer progression 11/16/2008

New step forward in search for solution to infection puzzle (8/7/2008)

Tags:
bacteria, infections

Scientists at the University of York have helped to reveal more about the way bacteria can attach to human tissues.

The study could help in the development of new treatments for serious heart conditions such as infective endocarditis.

The researchers studied the way a protein found on the surface of the bacteria Staphylococcus aureus binds to a human protein called fibronectin. Their discovery is an important step in understanding how bacteria attach to the surface of blood vessels during infection.

The high-resolution structures of parts of the bacterial protein in complex with multiple fibronectin domains reveals the efficiency with which the bacterial molecule can bind several copies of the human protein, a feature thought to play a role in infection.

Dr Jennifer Potts of the Departments of Biology and Chemistry at York, who led the research said: "Interactions of S. aureus with fibronectin were first reported more than 30 years ago, and yet we still don't understand precisely how and why the bacteria target this human protein.

"Our studies provide a significant step toward solving that issue and could help the future development of new treatments for rare but serious conditions such as infective endocarditis, an infection of the lining or valves of the heart."

The research is published in the latest issue of the Proceedings of the National Academy of Sciences (PNAS).

The work, which was funded by the British Heart Foundation, the Biotechnology and Biological Sciences Research Council, and the Wellcome Trust, was undertaken by Dr Richard Bingham and Dr Nicola Meenan (Biology, York) in collaboration with other scientists at the Universities of York, Oxford, St Andrews, UNAM and the TAMU Health Science Centre, Institute of Biosciences and Technology, Houston.

The research used the York Structural Biology Laboratory (YSBL) at the University of York and facilities at the European Synchrotron Radiation Facility (ESRF) in Grenoble.

Note: This story has been adapted from a news release issued by the University of York

Debt Consolidation - Cheap Gas - Loan - Credit Counseling

Post Comments:

Search

  Archives |  Submit News |  Advertise With Us |  Contact Us |  Links
All contents © 2000 - 2009 Web Doodle, LLC. All rights reserved.
Web Doodle, LLC does not provide medical advice, diagnosis or treatment. Please read our disclaimer